company background image
VTRS logo

Viatris NasdaqGS:VTRS Stock Report

Last Price

US$11.76

Market Cap

US$13.9b

7D

-0.08%

1Y

13.8%

Updated

25 Jul, 2024

Data

Company Financials +

Viatris Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Viatris
Historical stock prices
Current Share PriceUS$11.76
52 Week HighUS$13.62
52 Week LowUS$8.74
Beta0.94
11 Month Change14.06%
3 Month Change1.64%
1 Year Change13.84%
33 Year Change-17.70%
5 Year Change-42.13%
Change since IPO1,817.91%

Recent News & Updates

Viatris: Revenues, Debt, Valuation And Strategy Under The Microscope

Jun 13

Recent updates

Viatris: Revenues, Debt, Valuation And Strategy Under The Microscope

Jun 13

Viatris: Skeptics Proven Right Once Again

May 30

Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.

Apr 24

Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential

Apr 08

Viatris Stock Is Still Worth Buying

Mar 30

Up 25%, I Still Believe 4%-Yielding Viatris Is Up To 60% Undervalued

Mar 02

From Euphoria To Reality: Viatris' Tale Of Market Whirlwind

Jan 12

Viatris stock rises amid potential plans for €3B sale of European OTC assets

Oct 11

Take These Broken Wings And Learn To Fly Again Viatris

Sep 25

Viatris: 5% Dividend Yield Is A Threat For Investors

Sep 06

Viatris: Products, Profitability And Pipeline - The Keys To Success

Aug 20

Viatris declares $0.12 dividend

Aug 08

Viatris: A Spinoff To Own

Aug 02

Viatris extends decline to reach 52-week low

Jul 22

Viatris: Guidance Likely To Be Cut With Q2 Results

Jul 15

Shareholder Returns

VTRSUS PharmaceuticalsUS Market
7D-0.08%0.004%-2.4%
1Y13.8%18.8%17.5%

Return vs Industry: VTRS underperformed the US Pharmaceuticals industry which returned 18.8% over the past year.

Return vs Market: VTRS underperformed the US Market which returned 17.5% over the past year.

Price Volatility

Is VTRS's price volatile compared to industry and market?
VTRS volatility
VTRS Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: VTRS has not had significant price volatility in the past 3 months.

Volatility Over Time: VTRS's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196133,000Scott Smithwww.viatris.com

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

Viatris Inc. Fundamentals Summary

How do Viatris's earnings and revenue compare to its market cap?
VTRS fundamental statistics
Market capUS$13.93b
Earnings (TTM)-US$56.10m
Revenue (TTM)US$15.36b

0.9x

P/S Ratio

-249.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VTRS income statement (TTM)
RevenueUS$15.36b
Cost of RevenueUS$8.68b
Gross ProfitUS$6.68b
Other ExpensesUS$6.73b
Earnings-US$56.10m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 08, 2024

Earnings per share (EPS)-0.047
Gross Margin43.47%
Net Profit Margin-0.37%
Debt/Equity Ratio89.7%

How did VTRS perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

-1,025%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.